Kate Azizi is among the Portland Business Journal’s Women of Influence 2026 honorees.

OncoDaily ranks Brian Druker, M.D., among the 100 most influential CEOs in oncology in 2025.

research led by Kristin Prewitt, M.D., and Jamie Lo, M.D., that finds the rate of opioid use during pregnancy has risen two-fold over the past decade; Lo says: "The real situation is more dire and more severe”

The Washington Post profiles Portland dancers who raised money to buy art supplies, toys, sports equipment, costumes, puzzles and more for children receiving care at Doernbecher.

The Transmitter seeks an outside expert perspective from Marc Freeman, Ph.D., about a new study that finds astrocytes in mice secrete a type of protein that stabilizes circuits in the brain. He says all those cell types in the brain “are a lot for one molecule to coordinate.”

In a Portland Monthly story about health educators adopting new practices to combat bias against people with larger bodies, Hannah Cory, Ph.D., says faculty members at the OHSU-Portland State University School of Public Health are focused on changing attitudes in the health care workforce: “People will say, ‘Come back to me after you’ve lost weight.’ Deterring people from getting health care is not what public health is about.”

Clonell Therapeutics, Inc., of Yongin, South Korea announces the launch of the world’s first patient-specific embryonic stem cell therapy platform based on somatic cell nuclear transfer technology established at OHSU in 2013.

In a Parents magazine story about parents obsessing over various milestones for infants, Marlo Lenox McIlraith, M.D., says, “Milestones are a tool, not a test. Babies change in an instant.”

Continued news coverage about an OHSU evidence review that finds short-term improvements in pain management for cannabis products relatively high in THC.

Continued coverage of OHSU research that finds the rates of opioid use during pregnancy has risen two-fold over the past decade.